Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Cytosorbents Cor (CTSO)

Cytosorbents Cor (CTSO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Results and Business Update PR Newswire - Mon Jan 12, 6:00AM CST

Fourth quarter and Full-Year 2025 revenue are expected to be approximately   $9.2 million and $37.0 million, respectively, with expected Q4 gross margins in the range of 73% to 75%

CTSO : 0.7020 (+1.64%)
CytoSorbents to Participate in a Virtual Fireside Chat with D. Boral Capital on Monday, December 15, 2025 PR Newswire - Wed Dec 10, 2025

PRINCETON, N.J. , Dec. 10, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...

CTSO : 0.7020 (+1.64%)
Updated: CytoSorbents to Present at the Jefferies Global Healthcare Conference in London PR Newswire - Mon Nov 17, 2025

PRINCETON, N.J. , Nov. 17, 2025 /PRNewswire/ --  CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...

CTSO : 0.7020 (+1.64%)
CytoSorbents: Q3 Earnings Snapshot AP - Thu Nov 13, 2025

CytoSorbents: Q3 Earnings Snapshot

CTSO : 0.7020 (+1.64%)
CytoSorbents Reports Third Quarter 2025 Financial Results and Provides Business Update PR Newswire - Thu Nov 13, 2025

PRINCETON, N.J. , Nov. 13, 2025 /PRNewswire/ --  CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...

CTSO : 0.7020 (+1.64%)
CytoSorbents to Participate at the Jefferies Global Healthcare Conference in London PR Newswire - Tue Nov 11, 2025

PRINCETON, N.J. , Nov. 11, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...

CTSO : 0.7020 (+1.64%)
CytoSorbents to Report Third Quarter 2025 Financial Results and Recent Business Highlights PR Newswire - Thu Oct 30, 2025

PRINCETON, N.J. , Oct. 30, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...

CTSO : 0.7020 (+1.64%)
In Memoriam: Dr. Robert Hawes Bartlett (1939-2025) - Father of Extracorporeal Membrane Oxygenation (ECMO) and Former CytoSorbents Chief Medical Officer PR Newswire - Tue Oct 28, 2025

PRINCETON, N.J. , Oct. 28, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...

CTSO : 0.7020 (+1.64%)
Cytosorbents Faces Nasdaq Non-Compliance Notice Tipranks - Sat Oct 4, 2025

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Cytosorbents...

CTSO : 0.7020 (+1.64%)
CytoSorbents to Showcase Pioneering New Cardiac Surgery Data in Key Applications at the EACTS 2025 Annual Meeting in Copenhagen PR Newswire - Mon Sep 29, 2025

PRINCETON, N.J. , Sept. 29, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit...

CTSO : 0.7020 (+1.64%)

Barchart Exclusives

1 Top Penny Stock to Watch Now Barchart - Sat Jan 17, 11:00AM CST
This small-cap biotech is chasing a big breakthrough in 2026. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot